Published on in Vol 13 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/72424, first published .
A Machine Learning Approach to Predicting Mortality Risk in Chemotherapy-Treated Lung Cancer: Machine Learning Model Development and Validation

A Machine Learning Approach to Predicting Mortality Risk in Chemotherapy-Treated Lung Cancer: Machine Learning Model Development and Validation

A Machine Learning Approach to Predicting Mortality Risk in Chemotherapy-Treated Lung Cancer: Machine Learning Model Development and Validation

Jianjun Zou   1, 2, 3 * , MD ;   Jinyi Huang   4 * , MD ;   Katie Lu   5 * , BD ;   Ao Lin   4, 6, 7 , MD, PhD ;   Chen Xie   4 , MD ;   Jinrong Zhang   4 , MD ;   Boqi Rao   4, 6, 8 , MD, PhD ;   Zhi Li   4 , MD ;   Dongming Xie   4 , MD ;   Ling Lu   4 , MD ;   Feng Luo   4 , BD ;   Jinbin Chen   9 , MD, PhD ;   Lei Yang   4, 10, 11 , MD, PhD ;   Fuman Qiu   4 , MD, PhD ;   Xin Zhang   6, 7, 12 , MD, PhD ;   Yibin Deng   13 , MD, PhD ;   Jiachun Lu   4, 10, 11 , MD, PhD

1 Institute of Tuberculosis, Guangzhou Medical University, Guangzhou, Guangdong, China

2 Guangzhou Key Laboratory of Tuberculosis Research, Guangzhou Chest Hospital, Guangzhou, Guangdong, China

3 Department of General Medicine, Guangzhou Chest Hospital, Guangzhou, Guangdong, China

4 School of Public Health, Guangzhou Medical University, Guangzhou, Guangdong, China

5 School of Medicine, University of Arizona, Tucson, AZ, United States

6 State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, Guangdong, China

7 Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China

8 Emergency Department, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

9 KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, China

10 The Key Laboratory of Advanced Interdisciplinary Studies, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China

11 The Institute for Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou, Guangdong, China

12 Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China

13 Centre for Medical Laboratory Science, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China

*these authors contributed equally

Corresponding Author:

  • Jiachun Lu, MD, PhD
  • School of Public Health
  • Guangzhou Medical University
  • Xinzao, Panyu District
  • Guangzhou 511436
  • China
  • Phone: 86 20 37103043
  • Email: jclu@gzhmu.edu.cn